Showing results (241-250 of 324) with videos related to

Sort By:
Pageof 33
Cognitive, Affective & Behavioral Neuroscience|March 19, 2025
Infraslow Closed-Loop Brain Training for Anxiety and Depression (ISAD): A pilot randomised, sham-controlled trial in adult females with internalizing disordersTyson M Perez, Divya B Adhia, Paul Glue, et al.
Frontiers in Molecular Biosciences|June 6, 2020
cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver FibrosisQi Cao, Xin Lu, Babak Behnam Azad, et al.
International Journal of Circumpolar Health|February 16, 2008
Psychoneuroendocrine effects of combined thyroxine and triiodothyronine versus tyrosine during prolonged Antarctic residenceLawrence A Palinkas, Kathleen R Reedy, Mark Smith, et al.
European Journal of Medicinal Chemistry|January 7, 2022
Discovery of G2019S-Selective Leucine Rich Repeat Protein Kinase 2 inhibitors with in vivo efficacyRobert K Leśniak, R Jeremy Nichols, Marcus Schonemann, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of 1H-Pyrazole Biaryl Sulfonamides as Novel G2019S-LRRK2 Kinase InhibitorsRobert K Leśniak, R Jeremy Nichols, Marcus Schonemann, et al.
Physiology & Behavior|July 14, 2007
Environmental influences on hypothalamic-pituitary-thyroid function and behavior in AntarcticaLawrence A Palinkas, Kathleen R Reedy, Marc Shepanek, et al.
European Journal of Medicinal Chemistry|September 1, 2022
Discovery of azaspirocyclic 1H-3,4,5-Trisubstitued pyrazoles as novel G2019S-LRRK2 selective kinase inhibitorsRobert K Leśniak, R Jeremy Nichols, Marcus Schonemann, et al.
Scandinavian Journal of Infectious Diseases|April 4, 2002
A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patientRoy F Chemaly, Susan B Fox, Luay M Alkotob, et al.
Trials|November 18, 2022
Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disordersTyson M Perez, Paul Glue, Divya B Adhia, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 2, 2013
Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trialJamie P Dwyer, Mohammed Sika, Gerald Schulman, et al.
Pageof 33